Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
April 25, 2019 Off

Gelesis Awarded $10.6 (€9.4) Million Grant to Support Commercial Manufacturing of PLENITY™

By BusinessWire

PLENITY manufacturing facility will be the first factory to commercially produce medical super-absorbent hydrogels synthesized from naturally derived building blocks…

April 25, 2019 Off

GenSight Biologics Announces Presentation of 72-Week Data from the REVERSE & RESCUE Phase III Trials of GS010 at the Annual Meeting of ARVO

By BusinessWire

PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Paris:SIGHT) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on discovering and developing innovative…

Moleculin recruited qualified patients and started trials for two of its portfolio drugs to supplement US efforts
April 25, 2019 Off

Moleculin recruited qualified patients and started trials for two of its portfolio drugs to supplement US efforts

By Dino Mustafić

US Biopharma Company Undertakes Anti-Cancer Clinical Trials in Poland, First
Patient Showing Positive Initial Treatment

April 25, 2019 Off

SanBio: SB623, an Investigational Product, Granted Advanced Therapy Medicinal Product Classification by European Medicines Agency

By BusinessWire

MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–The SanBio Group (SanBio Co., Ltd. and SanBio, Inc.)(TOKYO:4592), a scientific leader in regenerative medicine for neurological…

April 25, 2019 Off

Forbius: First Patient Dosed in a Phase 1b Myelofibrosis Trial of AVID200, a Novel TGF-beta 1 & 3 Inhibitor

By BusinessWire

Investigator-initiated trial to evaluate AVID200’s safety, anti-fibrotic activity, and ability to restore hematopoiesis in patients with myelofibrosis AVID200 is a…

April 24, 2019 Off

Human Papillomavirus Associated Diseases – Pipeline Insights, 2019 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Human Papillomavirus Associated Diseases – Pipeline Insights, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. The report…

April 24, 2019 Off

Secondary Progressive Multiple Sclerosis (SPMS) – Pipeline Insight, 2019 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Secondary Progressive Multiple Sclerosis (SPMS) – Pipeline Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. The…

April 24, 2019 Off

Pancreatic Ductal Adenocarcinoma – Pipeline Insight, 2019 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Pancreatic Ductal Adenocarcinoma – Pipeline Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. The report offers…

April 24, 2019 Off

McKesson Declares Quarterly Dividend April 24, 2019

By BusinessWire

IRVING, Texas–(BUSINESS WIRE)–The Board of Directors of McKesson Corporation (NYSE:MCK) today declared a regular dividend of thirty-nine cents per share…

April 24, 2019 Off

Revance to Release First Quarter 2019 Financial Results on Wednesday, May 8, 2019

By BusinessWire

Conference Call Scheduled for Wednesday, May 8, 2019 at 4:30 p.m. ET NEWARK, Calif.–(BUSINESS WIRE)–Revance Therapeutics, Inc. (Nasdaq: RVNC), a…

Posts pagination

Previous 1 … 3,253 3,254 3,255 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine